thymidine has been researched along with erbstatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, T; Imoto, M; Isshiki, K; Tajima, H; Takeuchi, T; Umezawa, K | 1 |
| Hamaguchi, M; Hayakawa, T; Iwata, H; Koike, T; Noguchi, T; Shinagawa, A; Suzuki, M; Yamashita, K | 1 |
2 other study(ies) available for thymidine and erbstatin
| Article | Year |
|---|---|
Inhibition of epidermal growth factor-induced DNA synthesis by tyrosine kinase inhibitors.
Topics: Animals; Cell Cycle; Cells, Cultured; DNA; Epidermal Growth Factor; ErbB Receptors; Hydroquinones; Kidney; Phosphorylation; Protein-Tyrosine Kinases; Rats; Thymidine | 1990 |
Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2).
Topics: Benzoquinones; Calcium-Calmodulin-Dependent Protein Kinases; DNA; Enzyme Activation; Genistein; Glycoproteins; Humans; Hydroquinones; Isoflavones; Lactams, Macrocyclic; Mitogen-Activated Protein Kinase 1; Osteosarcoma; Phosphorylation; Protease Inhibitors; Protein-Tyrosine Kinases; Proteins; Quinones; Rifabutin; Signal Transduction; Thymidine; Time Factors; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinases; Tritium; Tumor Cells, Cultured; Tyrosine | 1996 |